Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
398.8 USD +0.60% Intraday chart for Intuitive Surgical, Inc. +3.13% +18.22%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 8.03B Sales 2025 * 9.31B Capitalization 141B
Net income 2024 * 1.97B Net income 2025 * 2.27B EV / Sales 2024 * 17 x
Net cash position 2024 * 5.19B Net cash position 2025 * 7.75B EV / Sales 2025 * 14.4 x
P/E ratio 2024 *
72.9 x
P/E ratio 2025 *
63 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.60%
1 week+3.13%
Current month+7.61%
1 month+6.59%
3 months+5.33%
6 months+30.64%
Current year+18.22%
More quotes
1 week
379.67
Extreme 379.67
401.36
1 month
364.17
Extreme 364.17
401.36
Current year
320.26
Extreme 320.26
403.76
1 year
254.85
Extreme 254.85
403.76
3 years
180.07
Extreme 180.07
403.76
5 years
120.17
Extreme 120.1667
403.76
10 years
40.28
Extreme 40.28
403.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 66 07-10-18
Director/Board Member 71 10-03-31
More insiders
Date Price Change Volume
24-05-17 398.8 +0.60% 720,293
24-05-16 396.4 -0.74% 1,083,935
24-05-15 399.4 +3.96% 1,200,770
24-05-14 384.2 +0.87% 913,529
24-05-13 380.9 -1.51% 1,070,927

Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
398.8 USD
Average target price
420.4 USD
Spread / Average Target
+5.41%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW